<!doctype html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport"
          content="width=device-width, user-scalable=no, initial-scale=1.0, maximum-scale=1.0, minimum-scale=1.0">
    <meta http-equiv="X-UA-Compatible" content="ie=edge">
    <title>Document</title>
    <link rel="stylesheet" href="style.css">
</head>
<body>
<div class="circle-out">
    <div class="circle-rotate">
        <div class="circle-img">
            <div class="test">
                <div class="circle-text">
                    <p class="circle-title">$55</p>
                    <p class="circle-desc" >annual target price of dolutegravir regimen per person year in resource-limited settings </p>
                </div>
            </div>
            <div class="test">
                <div class="circle-text">
                    <p class="circle-title">15лю</p>
                    <p class="circle-desc" >number of people living with HIV without access to treatment </p>
                </div>
            </div>
            <div class="test">
                <div class="circle-text">
                    <p class="circle-title">7-10</p>
                    <p class="circle-desc" >years historically taken to introduce pioneering Hiv treatments in Africa </p>
                </div>
            </div>
            <div class="test">
                <div class="circle-text">
                    <p class="circle-title">3</p>
                    <p class="circle-desc" >number of years taken to introduce dolutegravir in Africa </p>
                </div>
            </div>
            <div class="test">
                <div class="circle-text">
                    <p class="circle-title">94</p>
                    <p class="circle-desc" >number of countries who can access generic versions of dolutegravir</p>
                </div>
            </div>
            <div class="test">
                <div class="circle-text">
                    <p class="circle-title">impact</p>
                    <p class="circle-desc" >US$ 270 million - annual savings possible from scale-up of dolutegravir-based regimens if</p>
                </div>
            </div>
        </div>
    </div>
</div>
</body>
</html>